1. MO-0141 Sulfasalazine radiosensitizes hypoxic colorectal cancer cells through the inhibition of xCT. (May 2022) Authors: Kerkhove, L.; Dufait, I.; De Ridder, M.; de Mey, S.; Geirnaert, F.; Law, K.L.; Vandenplas, H.; Gevaert, T. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1927 Disulfiram radiosensitizes hypoxic human colorectal cancer through inhibition of PHGDH. (August 2021) Authors: Van De Gucht, M.; Dufait, I.; Jiang, H.; Corbet, C.; de Mey, S.; Wang, H.; Vandenplas, H.; Law, K.L.; Gevaert, T.; Feron, O.; De Ridder, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1928 Radiation cooperates with modulation of serine in human hypoxic colorectal cancer cells. (August 2021) Authors: Van De Gucht, M.; Dufait, I.; Demesmaeker, E.; jiang, H.; Corbet, C.; de Mey, S.; Vandenplas, H.; Law, K.L.; Gevaert, T.; Feron, O.; De Ridder, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗